- Home
- GTY vs OCUL Comparison
GTY vs OCUL Comparison
Compare GTY & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTY | OCUL |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GTY | OCUL |
|---|---|---|
| Price | $32.88 | $8.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $32.60 | $23.56 |
| AVG Volume (30 Days) | 327.6K | ★ 2.6M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.92% | N/A |
| EPS Growth | ★ 8.00 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $221,727,000.00 | $1,990,000.00 |
| Revenue This Year | $9.39 | $7.93 |
| Revenue Next Year | $7.83 | $96.07 |
| P/E Ratio | $76.05 | ★ N/A |
| Revenue Growth | ★ 9.02 | 3.48 |
| 52 Week Low | $25.39 | $6.23 |
| 52 Week High | $34.75 | $16.44 |
Technical Indicators
Market Signals| Indicator | GTY | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 38.35 |
| Support Level | $32.56 | $8.36 |
| Resistance Level | $34.08 | $9.93 |
| Average True Range (ATR) | 0.48 | 0.45 |
| MACD | -0.06 | -0.11 |
| Stochastic Oscillator | 51.75 | 6.50 |
Price Performance
Historical ComparisonAbout GTY Getty Realty Corporation
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.